摘要 |
This invention relates to compounds which exhibit selective muscarinic M<SUB>3 </SUB>receptor antagonism, have little side effects, are suitable for inhalation therapy and are useful as treating agents of respiratory system diseases, of the general formula (I); [in which A signifies a group expressed by a formula (a<SUB>0</SUB>) or (b<SUB>0</SUB>); Ar signifies optionally substituted aryl or heteroaryl; B<SUP>1 </SUP>and B<SUP>2 </SUP>signify aliphatic hydrocarbon; R<SUP>1 </SUP>signifies fluorine-substituted cycloalkyl; R<SUP>2</SUP>, R<SUP>3 </SUP>and R<SUP>4 </SUP>signify lower alkyl, single bond or alkylene bonded to B<SUP>1</SUP>, or R<SUP>2 </SUP>and R<SUP>3 </SUP>are united to signify alkylene; R<SUP>5 </SUP>and R<SUP>7 </SUP>signify hydrogen, lower alkyl, or a single bond or alkylene bonded to B<SUP>2</SUP>; R<SUP>6 </SUP>signifies hydrogen, lower alkyl or a group expressed as -N(R<SUP>8</SUP>)R<SUP>9</SUP>; and X<SUP>-</SUP> signifies an anion].
|